Pharmaceuticals

Drug discovery, manufacturing, generics, patents, and commercialization pathways.

  • 10 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Pharmaceuticals


thehindubusinessline.com > economy > logistics > are-kirana-clusters-the-future-of-inclusive-retail > article71488628.ece

Are kirana clusters the future of inclusive retail?

50+ min ago   (294+ words) Though a valid concern, the solution need not necessarily be to stop the advance of platforms but to build new capabilities for kiranas to achieve successful coexistence. Can cooperation offer kiranas a practical logistics response? The Trichy engineering cluster is…...


brecorder.com > news > 40/44/0450 > gilani-says-automotive-industry-contributes-beyond-vehicle-production

Gilani says automotive industry contributes beyond vehicle production

56+ min ago   (467+ words) LAHORE: Senate Chairman Syed Yousaf Raza Gilani has said that a strong automotive industry contributes far beyond vehicle production, as it supports employment, engineering capabilities, technology transfer, localisation and a wider network of domestic suppliers. Addressing the Pakistan International Auto…...


slashgear.com > 2257863 > brands-owned-by-snap-on-tools

11 Brands Owned By Snap-On Tools

1+ hour, 33+ min ago   (778+ words) Snap-on has a long list of popular brands under its ownership, such as Hoffman, Hi-Force, and Bahco, all of which specialize in crafting high-precision tools and equipment for several industries. Those who used Snap-on tools mostly found them worth the…...


statnews.com > 09/20/2026 > radiopharma-companies-itm-telix-merger

Radiopharma companies merge after one receives surprise FDA rejection

2+ hour, 37+ min ago   (148+ words) ITM Isotope Technologies Munich SE and Telix Pharmaceuticals, two leading companies in the burgeoning radiopharmaceuticals field, are merging in a deal worth at least $1.65 billion. Under the deal, Telix will acquire all shares of the privately held company ITM. Telix…...


wsau.com > 09/20/2026 > australias-telix-pharma-agrees-to-buy-germanys-itm-isotope-for-about-1-65-billion

Australia’s Telix Pharma agrees to buy Germany’s ITM Isotope for about $1.65 billion

3+ hour, 2+ min ago   (107+ words) Sept 21 (Reuters) - Australia's Telix Pharmaceuticals ​said ‌on Monday it has ‌agreed ​to ⁠acquire Germany-based ⁠ITM Isotope Technologies Munich SE for ​about $1.65 billion ⁠on ⁠a ​cash- and ​debt-free basis. After adjustments, ‌ITM shareholders are e... Australia’s Telix Pharma agrees to buy…...


villages-news.com-news.com

Local retiree advocate warns Villagers to check mail for Medicare plan cancellations

3+ hour, 3+ min ago   (20+ words) With Medicare open enrollment fast approaching, a local retiree advocate is warning Villagers to pay close attention to their mail....


northsidesun.com > hitachi-energy-brings-largest-us-investment-date-mississippi

Hitachi Energy brings largest U.S. investment to date to Mississippi

3+ hour, 19+ min ago   (400+ words) The $528 million expansion project in Copiah County will increase the company’s production capacity and expand the range of small power transformers manufactured domestically, while creating over 650 jobs. Governor Tate Reeves and the Mississippi Development Authority announced Tuesday that Hitachi Energy…...


digitimes.com > news > a20/26/0918VL219 > technology-automotive-xpeng-business-volkswagen.html

Beyond Volkswagen, XPeng seeks to turn automotive R&D into a global tech enterprise

2+ day, 1+ hour ago   (28+ words) It has become increasingly evident that one of the factors undermining China's unparalleled competence in the global EV industry is manufacturing scale. But the continued development of proprietary......


kansascity.com > news > business > article317284764.html

Ultragenyx sets $3.95 million price for rare disease gene therapy

3+ day, 15+ hour ago   (373+ words) Sept 17 (Reuters) - Ultragenyx Pharmaceutical said on Thursday it has set a U.S. list price of $3.95 million for its newly approved gene therapy Fayuvi, launching one of the world's most expensive drugs as a one-time treatment for a rare, fatal childhood disease....